Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Array's Up-Coming Value Enhancing Catalysts
Seeking Alpha
Wed, 04/17/13 - 10:50 am
Tags:
Array Biopharma, Amgen, Novartis, AstraZeneca, selumetinib, MEK162, melanoma, non-small cell lung cancer
The Most Productive Drug Companies Of The Past 10 Years
Forbes
Tue, 04/16/13 - 10:24 am
Tags:
JNJ, GSK, Novartis, Pfizer, Bristol-Myers Squibb
Pfizer's New Breast Cancer Drug Could Be A Game Changer
Seeking Alpha
Mon, 04/15/13 - 08:40 am
Tags:
Pfizer, breast cancer, palbociclib, AstraZeneca, Novartis, GSK, Bristol-Myers Squibb
This Week in Biotech
Motley Fool
Sun, 04/14/13 - 12:18 pm
Tags:
Pfizer, Novartis, Acadia, Astex, AcelRx, Synergy Pharmaceuticals
Is Arena Really Launching A New Product And Expanding Its Pipeline?
Seeking Alpha
Tue, 04/9/13 - 02:48 pm
Tags:
Arena Pharmaceuticals, Novartis, Vivus
India reserves right to act on drug patents after Novartis case
Reuters
Tue, 04/9/13 - 09:48 am
Tags:
India, Novartis, patents
Can Bristol-Myers Squibb Compete In Immuno-Oncology?
Seeking Alpha
Mon, 04/8/13 - 11:03 am
Tags:
immuno-oncology, cancer, Bristol-Myers Squibb, AbbVie, Ariad Pharmaceuticals, JNJ, Eli Lilly, Novartis, Pfizer, Medivation, Erbitux, Yervoy, Sprycel, Orencia
A Critical Analysis Of Pfizer's Pipeline, Earnings And Valuation
Seeking Alpha
Fri, 04/5/13 - 10:23 am
Tags:
Pfizer, JNJ, GSK, Abbott Laboratories, Merck, Novartis
Can New Psoriasis Drugs Scratch Investors' Itch?
Investors.com
Thu, 04/4/13 - 01:52 pm
Tags:
investors, psoriasis, Amgen, Eli Lilly, Pfizer, Novartis, Celgene, Humira, AbbVie, Stelara, Remicade, Enbrel, apremilast, brodalumab, Xeljanz
Evolution Of Biotech Industry: A Quick Look At Diversification, Divesting And Partnering
Seeking Alpha
Thu, 04/4/13 - 09:24 am
Tags:
Amgen, Amarantus BioSciences, Novartis, Gilead, biotech, Roche, Teva
Pfizer, Novartis, Abbott weigh bids for Brazil's Ache - sources
Reuters
Wed, 04/3/13 - 09:48 am
Tags:
Pfizer, Novartis, Brazil, Abbott Labs, Ache Laboratorios Farmaceuticos, M&A
Zalicus: Renewing Partnership With Novartis Will Be Vital For 2013 Revenues
Seeking Alpha
Wed, 04/3/13 - 09:41 am
Tags:
Novartis, Zalicus, Z160
U.S. trade office reviewing India's Supreme Court drug ruling
Reuters
Wed, 04/3/13 - 08:39 am
Tags:
Novartis, Glivec, patents, India
Will Novartis decision impact U.S. drug prices?
Marketwatch
Tue, 04/2/13 - 09:53 am
Tags:
drug pricing, generics, patents, Glivec, Novartis, India
Tecfidera Raises The Bar For Biogen Idec
Seeking Alpha
Tue, 04/2/13 - 09:48 am
Tags:
MS, multiple sclerosis, Biogen Idec, Tecfidera, Novartis, Sanofi
Will This Court Decision Be a Thorn in the Side of Novartis?
Wall St. Cheat Sheet
Mon, 04/1/13 - 10:39 am
Tags:
Novartis, India, Gleevac, patents, Glivec
Novartis loses landmark India patent case on Glivec
Reuters
Mon, 04/1/13 - 10:32 am
Tags:
patents, Novartis, India, Gleevec, Glivec
Pfizer's Next Big Deal Will Generate Income For Novartis, Prevent Competitors' Initiative
Seeking Alpha
Fri, 03/29/13 - 10:54 am
Tags:
Pfizer, Novartis, breast cancer, palbociclib
FDA Approves Novartis' TOBI Podhaler
Yahoo/Zacks
Fri, 03/29/13 - 10:50 am
Tags:
FDA, Novartis, TOBI Podhaler, cystic fibrosis
How Much Will FDA Action On Invokana Affect Johnson And Johnson's Revenue And Stock Price?
Seeking Alpha
Thu, 03/28/13 - 10:23 am
Tags:
JNJ, FDA, Invokana, AstraZeneca, Bristol-Myers Squibb, Merck, Sanofi, Novo Nordisk, Novartis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.